Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumors × Kyphoplasty × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

atezolizumab 3 Docetaxel 3 pembrolizumab 2 olaparib 2 lenvatinib 2 Leucovorin 2 Irinotecan 2 Immune Checkpoint Inhibitors 2 Fluorouracil 2 Filgrastim 2 Capecitabine 2 zolbetuximab 1 tomivosertib 1 spartalizumab 1 somatostatin receptor 2 1 pralsetinib 1 pegylated granulocyte colony-stimulating factor 1 necitumumab 1 motesanib diphosphate 1 ipatasertib 1 inavolisib 1 entrectinib 1 ensartinib 1 dapagliflozin 1 cobimetinib 1 cemiplimab 1 cat's claw extract 1 balugrastim 1 anlotinib 1 alectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02700308 2022-07-28

KYPHO-01

Centre Leon Berard

Phase 2 Terminated

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡